Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.91 USD | +5.66% | -8.23% | -32.98% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.98% | 188M | |
+7.01% | 215B | |
+11.01% | 187B | |
+19.20% | 143B | |
+30.79% | 110B | |
+1.48% | 64.68B | |
+13.95% | 52.96B | |
-0.16% | 49.84B | |
-6.20% | 38.32B | |
+0.91% | 35.86B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Earnings Flash (NPCE) NEUROPACE Posts Q1 Revenue $18.1M, vs. Street Est of $17.3M